Bleeding diathesis: Difference between revisions
Line 336: | Line 336: | ||
| - | | - | ||
| - | | - | ||
| | |N | ||
| | |↑/N | ||
| | |N | ||
| | |N | ||
|N | |N | ||
| | | | ||
Line 356: | Line 356: | ||
| - | | - | ||
| - | | - | ||
| | |N | ||
| | |↑/N | ||
| | |N | ||
| | |N | ||
|N | |N | ||
| | | | ||
|- | |- | ||
| rowspan="12" |Coagulation factor disorders | | rowspan="12" |Coagulation factor disorders | ||
| colspan=" | | colspan="2" |[[Fibrinogen]] deficiency | ||
|Different types of the [[fibrinogen]] disorders: | |||
* [[Fibrinogen#Congenital afibrinogenemia|Congenital afibrinogenemia]] | |||
* [[Fibrinogen#Congenital hypofibrinogenemia|Congenital hypofibrinogenemia]] | |||
* [[Fibrinogen#Fibrinogen storage disease|Fibrinogen storage disease]] | |||
* [[Fibrinogen#Congenital dysfibrinogenemia|Congenital dysfibrinogenemia]] | |||
* [[Fibrinogen#Hereditary fibrinogen A.CE.B1-Chain amyloidosis|Hereditary fibrinogen Aα-Chain amyloidosis]] | |||
* [[Fibrinogen#Acquired dysfibrinogenemia|Acquired dysfibrinogenemia]] | |||
* [[Fibrinogen#Congenital hypodysfibrinogenemia|Congenital hypodysfibrinogenemia]][[Fibrinogen#Cryofibrinogenemia|Cryofibrinogenemia]] | |||
* [[Fibrinogen#Acquired hypofibrinogenemia|Acquired hypofibrinogenemia]] | |||
| | | | ||
* [[Epistaxis]] | * [[Epistaxis]] | ||
Line 381: | Line 390: | ||
| + | | + | ||
| + | | + | ||
| | | +/- | ||
| + | | + | ||
|N | |N | ||
Line 388: | Line 397: | ||
|↑ | |↑ | ||
|↑ | |↑ | ||
|The severity of bleeding in patients with fibrinogen disorders can be mild or severe, with higher bleeding risk in those with afibrinogenemia or lower levels of functional fibrinogen. The age of onset is also variable, with earlier onset in those with more severe deficiency. | | | ||
* Impaired fibrin cross linking or clot dissolution. | |||
* The severity of bleeding in patients with fibrinogen disorders can be mild or severe, with higher bleeding risk in those with afibrinogenemia or lower levels of functional fibrinogen. The age of onset is also variable, with earlier onset in those with more severe deficiency. | |||
|- | |- | ||
| colspan="3" |[[Prothrombin deficiency]] | | colspan="3" |[[Prothrombin deficiency]] | ||
Line 410: | Line 422: | ||
|↑ | |↑ | ||
|↑ | |↑ | ||
| | |<nowiki>-</nowiki> | ||
|- | |- | ||
| colspan="3" rowspan="1" |[[Factor V deficiency]] | | colspan="3" rowspan="1" |[[Factor V deficiency]] | ||
Line 475: | Line 487: | ||
|↑ | |↑ | ||
|N | |N | ||
| | |<nowiki>-</nowiki> | ||
|- | |- | ||
| colspan="3" rowspan="1" |[[Factor XII|Factor XII deficiency]] | | colspan="3" rowspan="1" |[[Factor XII|Factor XII deficiency]] | ||
Line 489: | Line 501: | ||
|N | |N | ||
|N | |N | ||
| | |N | ||
|↑ | |↑ | ||
|N | |N | ||
| | | | ||
|- | |- | ||
| colspan=" | | colspan="3" |[[High-molecular-weight kininogen|High molecular weight kininogen (HMWK)]] deficiency | ||
| | |Possibility of positive family history of bleeding | ||
| | |_ | ||
| | |_ | ||
| | |_ | ||
| | |_ | ||
| | |_ | ||
| | |N | ||
| | |N | ||
| | |N | ||
| | |↑ | ||
| | |N | ||
| | | | ||
|- | |- | ||
| colspan=" | | colspan="3" rowspan="1" |[[Prekallikrein]] deficiency | ||
| | | | ||
|_ | |||
|_ | |||
|_ | |||
|_ | |||
|_ | |||
|N | |||
|N | |||
|N | |||
|↑ | |||
|N | |||
| | | | ||
|- | |- | ||
Line 537: | Line 547: | ||
| | | | ||
| | | | ||
| | |Impaired fibrin cross linking or clot dissolution | ||
|- | |- | ||
| rowspan="3" |[[Hemophilia]] | | rowspan="3" |[[Hemophilia]] |
Revision as of 19:04, 10 September 2018
Bleeding diathesis main page |
|
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Mehrian Jafarizade, M.D [2], Nazia Fuad M.D.
Overview
Bleeding diathesis is unusual susceptibility to bleed due to hypo-coagulopathies. These diseases can occur due to a disorder of homeostasis, localized process (tissue injury), or medications. Bleeding diathesis can be resulted from vessel wall injury, platelet disorders, and coagulation factor disorders. Clinical manifestation of bleeding disorders can have a wide range of symptoms from asymptomatic to symptomatic massive and life threatening bleeding. Platelet disorders mostly have skin manifestations such as petechiae, and ecchymoses. In order to find the cause of hypo-coagulopathy; there are established laboratory tests, such as peripheral blood smear, platelet count and platelet function analysis, coagulation factor deficiencies and inhibitors, fibrinolysis tests (eg. D-dimer level), bleeding time, prothrombin time, activated partial thromboplastin time, thrombin time and reptilase time.
Homostasis
Hemostasis is the process of blood clot formation at the site of bleeding. This process has 4 main phases as below:
Platelet plug formation
Coagulation cascade
Antithrombotic control
Fibrinolysis
Classification
Disorders of hemostasis can be classified into two main categories: platelet disorders, and disorders of coagulation. Each category can be further classified as bellow:
Platelet disorders:
- Thrombocytopenia: platelet count less than 150,000 per mm3
- Thromobcytosis: platelet countcmore than 450,000 per mm3
- Qualitative Disorders of Platelet function such as Von Willebrand Disease, inherited or acquired functional disorders.
Coagulation disorders
- Vessel wall disorders: Endothelial cells are lining entire vessel walls all over the body. Endothelium is an active layer responsible for inflammatory responses, angiogenesis and blood cell interactions. Endothelial cells have a very important role in hemostasis and they are regulating blood fluidity by the balance of antithrombotic/prothrombotic and vasodilatory/vasoconstrictor effects.
- Metabolic and Inflammatory Disorders
- Inherited Disorders of the Vessel Wall
- Coagulation factor disorders:
- Fibrinogen deficiency
- Prothrombin deficiency
- Factor V deficiency
- Factor VII deficiency
- Factor X deficiency
- Factor XII deficiency
- HK deficiency
- Prekallikrein deficiency
- Factor XIII deficiency
- Hemophilia
- Disseminated Intravascular Coagulation
- Vitamin K Deficiency
- Coagulation Disorders Associated with Liver Failure
- Acquired Inhibitors of Coagulation Factors
Differential Diagnosis
Category | Sub-category | Diseases | History | Clinical manifestation | Laboratory testing | Comments | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Petechiae | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Platelet count | Bleeding time (BT) | Prothrombin time (PT) | Activated partial thromboplastin time (aPTT) | Thrombin time (TT) | ||||||
Platelet disorders | Thrombocytopenia | Infection-Induced thrombocytopenia |
|
+ | + | + | + | + | ↓ | ↑ | N | N | N | - | |
Medications-Induced thrombocytopenia |
|
+ | + | + | + | + | ↓ | ↑ | N | N | N | Most important par of treatment is discontinuing of the medication. | |||
Heparin-Induced thrombocytopenia |
|
+ | + | + | + | + | ↓ | ↑ | N | N | ↑ | For more information click here: Heparin-induced thrombocytopenia. | |||
Immune Thrombocytopenic Purpura (ITP) |
|
+ | + | + | + | + | ↓ | ↑ | N | N | N | - | |||
Inherited Thrombocytopenia |
|
+ | + | + | + | + | ↓ | ↑ | N | N | N | - | |||
Thrombotic Thrombocytopenic Purpura (TTP) | History of:
|
+ | + | + | + | + | ↓ | ↑ | N | N | N | - | |||
Hemolytic Uremic Syndrome | History of:
|
+ | + | + | + | + | ↓ | ↑ | N | N | N | - | |||
Thromobcytosis |
|
− | − | − | +/- | +/- | ↑ | Ν/↑ | ɴ | ɴ | N | - | |||
Qualitative Disorders of Platelet Function | Inherited Disorders of Platelet Function | Glanzmann’s thrombasthenia |
|
+ | + | + | - | Rare | N/↓ | ↑ | ɴ | ɴ | N |
| |
Bernard-Soulier syndrome |
|
+ | + | + | - | - | N/↓ | ↑ | N | N | N |
| |||
Platelet storage pool disorder (SPD): |
|
+ | + | + | - | - | N/↓ | ↑ | N | N | N |
| |||
Acquired Disorders of Platelet Function |
|
+ | + | + | +/- | +/- | N/↓ | ↑ | N | N | N | ||||
Von Willebrand Disease |
|
+ | + | + | +/- | +/- | ↑ | Ν | ↑ | ↑ | N | See the table below for the details about types. | |||
Vessel wall disorders | Metabolic and Inflammatory Disorders |
|
|
+ | + | +/- | - | - | N | ↑/N | N | N | N | ||
Inherited Disorders of the Vessel Wall |
|
+ | + | +/- | - | - | N | ↑/N | N | N | N | ||||
Coagulation factor disorders | Fibrinogen deficiency | Different types of the fibrinogen disorders: |
|
_ | + | + | +/- | + | N | ↑ | ↑ | ↑ | ↑ |
| |
Prothrombin deficiency |
|
+ | + | + | + | + | N | N | ↑ | ↑ | ↑ | - | |||
Factor V deficiency |
|
_ | + | + | + | + | N | ↑ | ↑ | ↑ | N | The severity of bleeding is only partly related to the degree of factor V deficiency. Some patients with undetectable plasma levels of factor V experience only relatively mild bleeding. | |||
Factor VII deficiency |
|
+ | + | + | N | ↑ | N | N | Thrombosis occurs in inherited factor VII deficiency most cases are associated with the administration of factor VII replacement therapy | ||||||
Factor X deficiency |
|
+ | + | + | + | + | N | N | ↑ | ↑ | N | - | |||
Factor XII deficiency |
|
_ | _ | _ | _ | _ | N | N | N | ↑ | N | ||||
High molecular weight kininogen (HMWK) deficiency | Possibility of positive family history of bleeding | _ | _ | _ | _ | _ | N | N | N | ↑ | N | ||||
Prekallikrein deficiency | _ | _ | _ | _ | _ | N | N | N | ↑ | N | |||||
Factor XIII deficiency | Impaired fibrin cross linking or clot dissolution | ||||||||||||||
Hemophilia | Type A deficiency |
|
_ | _ | + | + | + | Unaffected | Unaffected | Unaffected | Prolonged | N | |||
Type B deficiency |
|
_ | _ | + | + | + | Unaffected | N | N | ↑ | N | ||||
Type C deficiency |
|
_ | _ | + | Rare | Rare | N | N | N | ↑ | N | ||||
Rare diseases | Disseminated Intravascular Coagulation |
|
+ | + | _ | + | + | ↓ | ↑ | ↑ | ↑ | N | |||
Vitamin K Deficiency |
|
+ | + | + | + | + | N | ↑ | ↑ | Normal or mildly prolonged | N | ||||
Coagulation Disorders Associated with Liver Failure | |||||||||||||||
Acquired Inhibitors of Coagulation Factors |
Type of VWD | Type of factor deficiency | Prevalence | Inheritance pattern | Clinical manifestations | VWF activity | RIPA | Factor VIII | Plt levels | ||
---|---|---|---|---|---|---|---|---|---|---|
Type 1 | Quantitative/ partial | |||||||||
Type 2 | 2A | |||||||||
2B | ||||||||||
2M | ||||||||||
2N | ||||||||||
Type 3 |